Calls to the Cancer Information Service At Fox Chase Cancer Center Nearly Double After Breast Cancer Prevention Trial Announcement
PHILADELPHIA (May 28, 1999) -- The Cancer Information Service (CIS) at Fox Chase Cancer Center has reported an enormous amount of calls after the widely publicized national breast cancer prevention trial started on May 25. The 1-800-4-CANCER line is answered by professional cancer information specialists and is sponsored by the National Cancer Institute.
"Our call volume has more than doubled since the announcement of the new study," says Linda Fleisher, director of the Cancer Information Service. "The majority of the callers are asking about the breast cancer prevention trial called STAR. Women are eager to find out more about this study comparing tamoxifen and raloxifene. For them, the prevention trial could mean the difference between living with the fear of breast cancer or taking control by trying to reduce their risks."
While the 1-800 line is being used nationwide to handle questions about the prevention trial, only calls from southeastern Pennsylvania, New Jersey and Delaware are answered at Fox Chase. CIS has information about cancer-related services and resources in each region.
"We're glad that our free service can be helpful to women who are interested in the STAR trial," Fleisher adds. "It's also given us the opportunity to talk to callers about early detection practices."
The STAR trial (study of tamoxifen and raloxifene) compares the effectiveness of these two drugs and their side effects. Study participants must be postmenopausal, at least age 35, and have an increased risk of developing breast cancer.
The Cancer Information Service, a program of the National Cancer Institute, provides a nationwide telephone service for cancer patients and their families, the public, and health care professionals. CIS information specialists have extensive training in providing up-to-date and understandable information about cancer and cancer research. They can answer questions in English and Spanish and can send free printed material. The toll-free number of the CIS is 1-800-4-CANCER.
Fox Chase Cancer Center is one of 35 National Cancer Institute-designated comprehensive cancer centers in the nation. The Center's activities include basic and clinical research; prevention, detection and treatment of cancer; and community outreach programs.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.